BIOALPHA HOLDINGS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.08 MYR | -.--% |
|
-5.88% | -27.27% |
| Mar. 11 | Bioalpha Holdings Berhad Announces Change of Address | CI |
| Feb. 29 | Bioalpha Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 202.3 | 170.1 | 159.1 | 310.9 | 229.9 | 144.7 |
| Enterprise Value (EV) 1 | 180.5 | 152.9 | 157.3 | 294.8 | 201.9 | 107.8 |
| P/E ratio | 29.8 x | 17.2 x | 19.1 x | -6.61 x | -171 x | -2.77 x |
| Yield | 0.4% | 0.52% | - | - | - | - |
| Capitalization / Revenue | 3.62 x | 2.43 x | 2.5 x | 8.53 x | 2.38 x | 4.04 x |
| EV / Revenue | 3.23 x | 2.18 x | 2.47 x | 8.09 x | 2.09 x | 3.01 x |
| EV / EBITDA | 31.4 x | 9 x | 11.7 x | -11.6 x | 32.5 x | -2.75 x |
| EV / FCF | -10.5 x | -6.74 x | -14.5 x | 124 x | -29.4 x | -13.7 x |
| FCF Yield | -9.53% | -14.8% | -6.92% | 0.8% | -3.4% | -7.32% |
| Price to Book | 1.49 x | 1.15 x | 0.96 x | 1.93 x | 1.28 x | 0.91 x |
| Nbr of stocks (in thousands) | 809,249 | 810,199 | 860,209 | 1,110,471 | 1,210,061 | 1,378,072 |
| Reference price 2 | 0.2500 | 0.2100 | 0.1850 | 0.2800 | 0.1900 | 0.1050 |
| Announcement Date | 4/30/18 | 4/30/19 | 5/22/20 | 5/27/21 | 4/29/22 | 4/28/23 |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 55.92 | 70.09 | 63.67 | 36.46 | 96.72 | 35.8 |
| EBITDA 1 | 5.753 | 16.99 | 13.44 | -25.52 | 6.218 | -39.21 |
| EBIT 1 | 1.363 | 11.57 | 6.974 | -33.11 | -2.581 | -48.06 |
| Operating Margin | 2.44% | 16.5% | 10.95% | -90.82% | -2.67% | -134.26% |
| Earnings before Tax (EBT) 1 | 9.375 | 14.69 | 10.52 | -41.45 | -2.772 | -48.83 |
| Net income 1 | 7.865 | 11.59 | 8.316 | -41.15 | -1.286 | -47.83 |
| Net margin | 14.07% | 16.53% | 13.06% | -112.85% | -1.33% | -133.62% |
| EPS 2 | 0.008399 | 0.0122 | 0.009671 | -0.0423 | -0.001113 | -0.0379 |
| Free Cash Flow 1 | -17.21 | -22.69 | -10.88 | 2.373 | -6.861 | -7.891 |
| FCF margin | -30.78% | -32.37% | -17.09% | 6.51% | -7.09% | -22.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | 0.001000 | 0.001100 | - | - | - | - |
| Announcement Date | 4/30/18 | 4/30/19 | 5/22/20 | 5/27/21 | 4/29/22 | 4/28/23 |
1MYR in Million2MYR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 21.8 | 17.3 | 1.87 | 16.1 | 28 | 36.9 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -17.2 | -22.7 | -10.9 | 2.37 | -6.86 | -7.89 |
| ROE (net income / shareholders' equity) | 6.44% | 7.95% | 5.16% | -26% | -0.88% | -27.5% |
| ROA (Net income/ Total Assets) | 0.64% | 4.34% | 2.34% | -10.9% | -0.8% | -14.4% |
| Assets 1 | 1,236 | 266.7 | 355.6 | 378.7 | 161 | 332.9 |
| Book Value Per Share 2 | 0.1700 | 0.1800 | 0.1900 | 0.1400 | 0.1500 | 0.1200 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0100 | 0.0200 | 0.0200 | 0.0200 |
| Capex 1 | 12.8 | 16.4 | 12.3 | 5.22 | 9.91 | 3.13 |
| Capex / Sales | 22.93% | 23.41% | 19.29% | 14.31% | 10.25% | 8.74% |
| Announcement Date | 4/30/18 | 4/30/19 | 5/22/20 | 5/27/21 | 4/29/22 | 4/28/23 |
1MYR in Million2MYR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -27.27% | 23.6M | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
- Stock Market
- Equities
- BIOHLDG Stock
- Financials Bioalpha Holdings
